India Covid Vaccines fastest

India becomes frontrunner to develop COVID19 vaccine. Vaccine deadline meant to cut red tape, ICMR clarifies.

India has become one of the frontrunners in the global effort to develop a vaccine for the containment of COVID-19.

Government agencies have stepped up collaboration with private partners to fastrack the approval process needed for development of a potential COVID vaccine. Bharat Biotech and Zydus Cadilla have got the approvals from the Central Drug Standard Control Organisation to initiate human clinical trials for their indigenously developed vaccine after the pre-clinical trials.

ICMR and Bharat Biotech have joined hands for the development of potential COVID-19 vaccine called ‘Covaxin’. This is the first indigenous vaccine being developed by India and one of the top priority projects of the government.

The vaccine is derived from a strain SARS-COV2 isolated by ICMR-National Institute of Virology, Pune and transferred to Bharat Biotech. The vaccine being tested by Zydus’ vaccine was developed indigenously at the company’s Vaccine Technology Centre in Ahmedabad after completing the pre-clinical phase.

In the coming months, human clinical trials will be done to identify the efficancy of these potential vaccine. Bharat Biotech and Zydus Cadilla have stepped up efforts to meet the target, however, final outcome will depend on the cooperation of all clinical sites involved in this project.

Meanwhile, India is also participating in the WHO solidarity trial which is an international clinical trial to compare four treatment options to assess their effectiveness against COVID-19. Another top Indian pharma company Serum Institute of India has bagged a contract with British drugmaker AstraZeneca to supply one billion doses of Oxford University’s potential COVID-19 vaccine.

Indian Council of Medical Research, ICMR has asserted that it is acting in accordance with the globally accepted norms to fast-track vaccine development for diseases of pandemic potential. 

It said, it is important to promote indigenous vaccine development while ensuring safety, quality, ethics and adherence to all regulatory requirement. 

ICMR and Bharat Biotech have joined hands for the development of potential COVID-19 vaccine called Covaxin. The Drugs Controller General of India has accorded permission to conduct phase-1 and 2 human clinical trial

Published by Naresh Sagar

Mentor MSME, Motivator, Media Event Org, Management fiscal & Water management.Social Media branding,Internet broadcasters,Propunder of Indian Philosophy

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: